Loop vs. Anchor Tenodesis of the Long Head of the Biceps Brachii Tendon

Loop vs. Anchor Tenodesis of the Long Head of the Biceps Brachii Tendon. A Prospective, Randomized, Double-blinded Study

The goal of this clinical trial is to learn if loop tenodesis is as effective as suture anchor tenodesis for treating long head of biceps (LHB) pathology. It will also assess the safety and outcomes of both techniques. The main questions it aims to answer are:

How effective is loop tenodesis compared to suture anchor tenodesis in preventing shoulder deformities and maintaining biomechanical strength? What complications or failures occur with each technique? Researchers will compare suture anchor tenodesis using the Arthrex FiberTak system with loop tenodesis (an implant-free technique).

Participants will:

Undergo surgery with either suture anchor tenodesis or loop tenodesis, assigned randomly.

Be informed about the procedure and sign a consent form prior to surgery. Have their clinical outcomes evaluated and compared before and after their treatment.

Study Overview

Detailed Description

A pathology of the long head of the biceps tendon (LHB) is often the cause of shoulder pain. There are numerous ways to treat an LHB pathology. Arthroscopic biceps tenotomy is a simple method to address this condition. However, it often results in a cosmetic "Popeye deformity" and reduced strength during abduction. For this reason, and due to advancements in anchor systems, arthroscopic biceps tenodesis using an anchor in the bicipital groove is becoming increasingly popular. The advantage of this method is that it prevents potential muscle deformity and provides stable fixation in the bicipital groove. Possible disadvantages include potential failure and the cost of the anchors used.

A newer method with good biomechanical and clinical outcomes is the so-called arthroscopic loop tenodesis. In this technique, the LHB is proximally detached at its insertion and shuttled extracapsularly using a clamp. The end of the tendon is then folded and sutured into a so-called "loop." The tendon is released, and after spontaneous retraction, it forms a so-called autotenodesis in the bicipital groove. This technique has the advantage of providing implant-free fixation while also demonstrating good biomechanical outcomes.

The goal of this study is to investigate and compare the clinical success rate after arthroscopic treatment of the LHB using either a suture anchor tenodesis (Arthrex FiberTak) or the so-called loop tenodesis (implant-free fixation). The study is being conducted in the Orthopedics Department of the Ordensklinikum Linz - Barmherzige Schwestern, Austria.

All patients requiring arthroscopic biceps tenodesis at the Orthopedics Department of the Ordensklinikum Linz will be treated using either suture anchor tenodesis or loop tenodesis. Allocation to the surgical technique will be determined by block randomization (block length = 9) immediately after the decision to include the patient in the study. Block randomization using a random number generator is chosen to ensure that the group sizes are approximately equal.

Before surgery, patients will be informed about the study process and the possibility of participation during a personal consultation. They will also receive a patient information and consent form in which their agreement to participate is documented in writing. Patients will receive a copy of the signed consent form, while the original remains with the investigator.

The data collected in this study will be analyzed individually and compared with existing data in the literature. The results will then be taken into account when considering various treatment concepts, potentially leading to adjustments or optimizations to benefit the patients.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 4020
        • Ordensklinikum Linz Barmherzige Schwestern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All patients requiring a tenodesis of the long head of the biceps tendon during the study period, using either anchor tenodesis or loop tenodesis.
  • Patients must be at least 18 years old.
  • Patients must have the capacity to give informed consent.

Exclusion Criteria:

  • Patients with insufficient documentation.
  • Patients under the age of 18.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Loop tenodesis of Long head of biceps tendon
Long head of biceps tenodesis using loop technique
Loop tenodesis of the long head of biceps tendon.
Active Comparator: Anchor tenodesis of Long head of biceps tendon
Long head of biceps tenodesis using anchor technique
Anchor Tenodesis of Long head of biceps tendon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constant-Murley Score
Time Frame: up to 24 months
score ranges from 0 to 100 points, representing worst and best shoulder function
up to 24 months
American Shoulder and Elbow Surgeons score (ASES)
Time Frame: up to 24 months
ranges from 0 to 100, with 0 the lowest level of function and 100 the highest level of function
up to 24 months
Disabilities of the arm, shoulder and hand (DASH) outcome questionnaire
Time Frame: up to 24 months
scored 0 (no disability) to 100
up to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cosmetic Outcome
Time Frame: up to 24 months
Incidence of "Popeye deformity" post-surgery
up to 24 months
Strength
Time Frame: up to 24 months
Supination of the forearm in 90 degree elbow flexion in kilogram
up to 24 months
Complications
Time Frame: up to 24 months
Rate of complications (anchor failure, Pop-eye deformity, infections, pain etc.)
up to 24 months
Pain (pre-/postOP)
Time Frame: up to 24 months
assessed using a Visual Analog Scale (VAS). two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be')
up to 24 months
Sport activities
Time Frame: up to 24 months
assessed using a questionnaire
up to 24 months
Level of sport
Time Frame: up to 24 months
assessed using a questionnaire (amateur (no salary), professional (salary)
up to 24 months
Sport duration
Time Frame: up to 24 months
assessed using a questionnaire (1x/2x/3x/4x/>4x per week; 0-15 min, 16-30 min, 31-60 min, 61-120 min, > 120 min per day)
up to 24 months
Return to sport
Time Frame: up to 24 months
assessed using a questionnaire (months)
up to 24 months
Pain during sport
Time Frame: up to 24 months
assessed using a questionnaire with virtual analag scale (pre- and postOP; VAS 0-10, 0= no pain, 10= maximal pain)
up to 24 months
Fear during sport
Time Frame: up to 24 months
assessed using a questionnaire with virtual analog scale (pre- and postOP; VAS 0-10, 0= no fear, 10= maximal fear)
up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

August 31, 2024

Study Completion (Actual)

April 30, 2025

Study Registration Dates

First Submitted

December 1, 2024

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

February 7, 2025

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD can be shared upon request, due to government privacy policy routine uploading of specific data can not be done.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Arthroscopic Surgery

Clinical Trials on Arthroscopic Loop tenodesis of long head of biceps.

Subscribe